Sands Capital Management, LLC Repligen Corp Transaction History

Sands Capital Management, LLC

$27.6 Billion
Q1 2025

A detailed history of Sands Capital Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Sands Capital Management, LLC holds 1,294,196 shares of RGEN stock, worth $160 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

1,294,196

Previous 1,364,258 5.14%

Holding current value

$160 Million

Previous $196 Million 16.14%

% of portfolio

0.6%

Previous 0.62%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$127.24 - $174.24 $8.91 Million - $12.2 Million	-70,062 Reduced 5.14%	1,294,196 $165 Million
Q4 2024 Feb 13, 2025	SELL	$123.41 - $160.92 $6.76 Million - $8.82 Million	-54,805 Reduced 3.86%	1,364,258 $196 Million
Q3 2024 Nov 13, 2024	SELL	$119.79 - $167.35 $295,761 - $413,187	-2,469 Reduced 0.17%	1,419,063 $211 Million
Q2 2024 Aug 13, 2024	SELL	$120.0 - $182.95 $1.34 Million - $2.05 Million	-11,205 Reduced 0.78%	1,421,532 $179 Million
Q1 2024 May 14, 2024	SELL	$170.78 - $208.42 $10.7 Million - $13 Million	-62,600 Reduced 4.19%	1,432,737 $264 Million
Q4 2023 Feb 13, 2024	SELL	$114.17 - $185.35 $8.57 Million - $13.9 Million	-75,026 Reduced 4.78%	1,495,337 $269 Million
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $3.31 Million - $4.2 Million	-23,816 Reduced 1.49%	1,570,363 $250 Million
Q2 2023 Aug 15, 2023	SELL	$138.42 - $180.31 $2.86 Million - $3.73 Million	-20,672 Reduced 1.28%	1,594,179 $226 Million
Q1 2023 May 12, 2023	SELL	$154.26 - $198.1 $25.7 Million - $33 Million	-166,588 Reduced 9.35%	1,614,851 $272 Million
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $23.1 Million - $31.4 Million	142,480 Added 8.69%	1,781,439 $302 Million
Q3 2022 Nov 09, 2022	BUY	$160.42 - $256.21 $263 Million - $420 Million	1,638,959 New	1,638,959 $307 Million

Others Institutions Holding RGEN

# of Institutions

492

Shares Held

57.7M

Call Options Held

75.6K

Put Options Held

523K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.84B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sands Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sands Capital Management, LLC with notifications on news.

Account

Sands Capital Management, LLC Repligen Corp Transaction History